Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 6 de 6
Filtrer
1.
Am J Trop Med Hyg ; 111(1): 48-50, 2024 Jul 03.
Article de Anglais | MEDLINE | ID: mdl-38834082

RÉSUMÉ

Infections caused by free-living amoebae pose a significant public health threat owing to growing populations of immunocompromised hosts combined with diagnostic delays, treatment difficulties, and high case fatality rates. Nasopharyngeal infections caused by Acanthamoeba are rare and the optimal treatment is not well established. We report a case of Acanthamoeba rhinosinusitis in a patient with chronic lymphocytic leukemia who presented with headaches and chronic rhinosinusitis refractory to multiple courses of antibiotics. A diagnosis of Acanthamoeba rhinosinusitis was established through broad-range polymerase chain reaction testing on sinus tissue. The patient had a favorable response to treatment, which included surgical debridement, cessation of immunosuppressants, and a three-drug regimen consisting of miltefosine, fluconazole, and sulfadiazine.


Sujet(s)
Acanthamoeba , Amibiase , Leucémie chronique lymphocytaire à cellules B , Rhinite , Sinusite , Humains , Leucémie chronique lymphocytaire à cellules B/complications , Leucémie chronique lymphocytaire à cellules B/traitement médicamenteux , Sinusite/traitement médicamenteux , Sinusite/parasitologie , Sinusite/diagnostic , Acanthamoeba/isolement et purification , Acanthamoeba/génétique , Rhinite/traitement médicamenteux , Rhinite/diagnostic , Rhinite/parasitologie , Amibiase/traitement médicamenteux , Amibiase/diagnostic , Mâle , Sujet immunodéprimé , Adulte d'âge moyen , Fluconazole/usage thérapeutique , Sujet âgé , Antiprotozoaires/usage thérapeutique , , Phosphoryl-choline/analogues et dérivés
2.
BMJ Qual Saf ; 33(8): 487-498, 2024 Jul 22.
Article de Anglais | MEDLINE | ID: mdl-38782579

RÉSUMÉ

BACKGROUND: Hospital-onset bacteraemia and fungaemia (HOB) is being explored as a surveillance and quality metric. The objectives of the current study were to determine sources and preventability of HOB in hospitalised patients in the USA and to identify factors associated with perceived preventability. METHODS: We conducted a cross-sectional study of HOB events at 10 academic and three community hospitals using structured chart review. HOB was defined as a blood culture on or after hospital day 4 with growth of one or more bacterial or fungal organisms. HOB events were stratified by commensal and non-commensal organisms. Medical resident physicians, infectious disease fellows or infection preventionists reviewed charts to determine HOB source, and infectious disease physicians with training in infection prevention/hospital epidemiology rated preventability from 1 to 6 (1=definitely preventable to 6=definitely not preventable) using a structured guide. Ratings of 1-3 were collectively considered 'potentially preventable' and 4-6 'potentially not preventable'. RESULTS: Among 1789 HOB events with non-commensal organisms, gastrointestinal (including neutropenic translocation) (35%) and endovascular (32%) were the most common sources. Overall, 636/1789 (36%) non-commensal and 238/320 (74%) commensal HOB events were rated potentially preventable. In logistic regression analysis among non-commensal HOB events, events attributed to intravascular catheter-related infection, indwelling urinary catheter-related infection and surgical site infection had higher odds of being rated preventable while events with neutropenia, immunosuppression, gastrointestinal sources, polymicrobial cultures and previous positive blood culture in the same admission had lower odds of being rated preventable, compared with events without those attributes. Of 636 potentially preventable non-commensal HOB events, 47% were endovascular in origin, followed by gastrointestinal, respiratory and urinary sources; approximately 40% of those events would not be captured through existing healthcare-associated infection surveillance. DISCUSSION: Factors identified as associated with higher or lower preventability should be used to guide inclusion, exclusion and risk adjustment for an HOB-related quality metric.


Sujet(s)
Bactériémie , Infection croisée , Fongémie , Humains , Études transversales , Bactériémie/épidémiologie , Bactériémie/prévention et contrôle , États-Unis/épidémiologie , Infection croisée/prévention et contrôle , Infection croisée/épidémiologie , Mâle , Femelle , Fongémie/épidémiologie , Adulte d'âge moyen , Indicateurs qualité santé , Sujet âgé
3.
Cureus ; 15(6): e40318, 2023 Jun.
Article de Anglais | MEDLINE | ID: mdl-37448416

RÉSUMÉ

Rosemonas species has been associated with infections in both immunocompetent and immunocompromised hosts, manifesting as peritonitis, bacteremia, catheter-related bacteremia, endophthalmitis, spondylitis, and endocarditis. Here we present a man in his 60s who was brought to our institution for sudden onset of aphasia, right-sided paresthesia, and new onset tonic-clonic seizure episodes. At presentation, he was found to have severe lactic acidosis, acute kidney failure, bilateral hydronephrosis, elevated prostate-specific antigen (PSA), and an enlarged prostate. Blood cultures obtained on admission later grew Roseomonas species for which he was started on meropenem. A trans-esophageal echocardiogram (TEE) showed multiple very thin mobile densities on the ventricular side of the aortic valve; magnetic resonance imaging (MRI) of the brain revealed an 11 mm acute/subacute hemorrhage. The patient was discharged in stable condition on Ertapenem intravenous therapy for six weeks. Roseomonas mucosa can be a cause of endocarditis. The antimicrobial resistance profile of Roseomonas spp suggests that carbapenems, fluoroquinolones or aminoglycosides are the drugs of choice for Roseomonas infections and that infectious diseases involved in cases of Roseomonas infections should be instituted promptly for proper management.

4.
Infect Dis Clin North Am ; 35(2): 493-514, 2021 06.
Article de Anglais | MEDLINE | ID: mdl-34016288

RÉSUMÉ

Cryptococcosis is an invasive fungal infection of global significance caused by yeasts of the genus Cryptococcus. The prevalence of HIV in certain areas of the world and the expanding population of immunocompromised patients contribute to the ongoing global disease burden. Point-of-care serologic testing has allowed for more rapid diagnosis and implementation of screening programs in resource-limited settings. Management involves therapy aimed at reduction in fungal burden, maintenance of intracranial pressure, and optimization of host immunity. Despite diagnostic and therapeutic advances, cryptococcosis continues to be a disease with unacceptably high incidence and mortality, particularly in resource-limited settings.


Sujet(s)
Cryptococcose/épidémiologie , Cryptococcus gattii/isolement et purification , Cryptococcus neoformans/isolement et purification , Séropositivité VIH/complications , Infections fongiques invasives/épidémiologie , Cryptococcose/diagnostic , Cryptococcose/traitement médicamenteux , Cryptococcus gattii/immunologie , Cryptococcus neoformans/immunologie , Séronégativité VIH , Humains , Syndrome inflammatoire de restauration immunitaire , Immunocompétence , Sujet immunodéprimé , Incidence , Infections fongiques invasives/diagnostic , Infections fongiques invasives/traitement médicamenteux , Méningite , Transplantation d'organe
5.
Trop Med Infect Dis ; 6(1)2021 Feb 14.
Article de Anglais | MEDLINE | ID: mdl-33672796

RÉSUMÉ

Nipah virus (NiV) is a zoonotic paramyxovirus of the Henipavirus genus first identified in Malaysia in 1998. Henipaviruses have bat reservoir hosts and have been isolated from fruit bats found across Oceania, Asia, and Africa. Bat-to-human transmission is thought to be the primary mode of human NiV infection, although multiple intermediate hosts are described. Human infections with NiV were originally described as a syndrome of fever and rapid neurological decline following contact with swine. More recent outbreaks describe a syndrome with prominent respiratory symptoms and human-to-human transmission. Nearly annual outbreaks have been described since 1998 with case fatality rates reaching greater than 90%. The ubiquitous nature of the reservoir host, increasing deforestation, multiple mode of transmission, high case fatality rate, and lack of effective therapy or vaccines make NiV's pandemic potential increasingly significant. Here we review the epidemiology and microbiology of NiV as well as the therapeutic agents and vaccines in development.

6.
Am J Infect Control ; 47(3): 343-345, 2019 03.
Article de Anglais | MEDLINE | ID: mdl-30458995

RÉSUMÉ

Timely removal of the urinary catheter is an important strategy for decreasing catheter-associated urinary tract infections (CAUTIs). Data were aggregated from an electronic root cause analysis tool, which is used to collect and guide discussions on patient factors following a CAUTI event at our facility. This identified the Braden Scale score as a possible important predictor of early-onset CAUTI in high-risk patients and could potentially be leveraged for early action in urinary catheter removal.


Sujet(s)
Infections sur cathéters/prévention et contrôle , Règles de décision clinique , Cathétérisme urinaire/effets indésirables , Infections urinaires/prévention et contrôle , Adolescent , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Femelle , Humains , Mâle , Adulte d'âge moyen , Études rétrospectives , Appréciation des risques , Analyse de cause racine , Abstention thérapeutique , Jeune adulte
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE